Hearing Aids for Hearing Loss

N/A

Waitlist Available

Research Sponsored by Sonova AG

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult, age 18 - 95 years

N4 hearing loss

Must not have

Normal hearing, or hearing loss outside the specified range

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from enrollment to the completion of data collection, approximately 6 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study how well hearing aids work in different environments for adults with hearing loss. It will look at how different features of the hearing aids perform in various settings and which features users prefer.

Who is the study for?

This trial is for adults aged 18-95 with N4 hearing loss who have used hearing aids before and can speak, read, and write English fluently. They should be able to complete complex listening tasks without cognitive impairments. People with normal hearing or outside the specified range, no experience with hearing aids, or any condition that affects study participation are excluded.

What is being tested?

The trial is testing how different features of a new hearing instrument perform in various environments. Adults with hearing loss will use these instruments at home and provide feedback through questionnaires about their preferences and the performance of the device's features.

What are the potential side effects?

Since this trial involves non-invasive interventions (hearing instruments), side effects may not be as common as drug trials but could include discomfort from wearing the device or challenges adapting to new auditory inputs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 95 years old.

Select...

I have severe hearing loss.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My hearing is normal or not severely impaired.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from enrollment to the completion of data collection, approximately 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from enrollment to the completion of data collection, approximately 6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to the completion of data collection, approximately 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Hearing instrument feature performance

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Hearing Aid UsersExperimental Treatment1 Intervention

Participants will wear hearing instruments for the duration of the study period. They will be asked to complete questionnaires about their environment and experience.

0 / 3Eligibility criteria met